27 August 2024 : Original article
Early Post-Transplant Serum Ferritin Levels as Predictive Biomarkers for Severe Acute Graft-Versus-Host Disease in Pediatric Umbilical Cord Blood Transplantation for Acute Leukemia
Zhiqi Zhang1ABCDEF, Bohan Li1ABCDEF, Lu Liu2ABCDEF, Ruolan Xiong1BCDE, Senlin Zhang3ABC, Minyuan Liu1ABC, Zihao Xia1BCE, Shuran Wang1BCE, Jie Li1CDEFG, Shaoyan Hu14ABCDEFG*DOI: 10.12659/AOT.944156
Ann Transplant 2024; 29:e944156
Table 2 Risk factors for the occurrence of III–IV acute graft-versus-host disease in pediatric patients undergoing allogeneic hematopoietic stem-cell transplantation.
Risk factors | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Age | 0.99 | 0.89–1.12 | 0.920 | |||
Sex female vs male | 1.27 | 0.51–3.17 | 0.600 | |||
Disease (AL type) | 1.94 | 0.80–4.73 | 0.140 | |||
HLA matching | 0.46 | 0.18–1.14 | 0.093* | 0.45 | 0.18–1.17 | 0.100 |
ABO matching | 1.27 | 0.46–3.51 | 0.640 | |||
Disease status at transplant | ||||||
CR1 | 1.65 | 0.61–4.48 | 0.330 | |||
CR2 | 0.51 | 0.12–2.17 | 0.360 | |||
PR | 1.19 | 0.37–3.84 | 0.770 | |||
NR | Reference | |||||
Conditioning intensity | 0.32 | 0.13–0.81 | 0.017* | 0.34 | 0.13–0.89 | 0.027 |
ATG | 0.50 | 0.12–2.04 | 0.330 | |||
Conditioning drug dose | ||||||
Bu | 0.92 | 0.69–1.23 | 0.560 | |||
CTX | 0.98 | 0.95–1.02 | 0.340 | |||
Neutrophil engraftment time | 1.00 | 0.90–1.12 | 0.950 | |||
Platelet engraftment time | 1.01 | 0.97–1.05 | 0.610 | |||
Total infused cell count | ||||||
MNC | 1.03 | 0.85–1.24 | 0.800 | |||
CD34+ | 1.01 | 0.81–1.27 | 0.900 | |||
SF level within 2 weeks post-transplant | 3.98 | 1.16–13.60 | 0.028* | 3.61 | 1.09–11.97 | 0.036 |
SF level within 2 weeks pretransplant | 1.97 | 0.66–5.89 | 0.220 | |||
AL – acute leukemia; ATG – anti-thymocyte globulin; Bu – busulfan; CI – confidence interval; CR – complete response; CTX – cyclophosphamide; HR – hazard ratio; MNC – mononuclear cells; NR – no response; PR – partial response; SF – serum ferritin. |